Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NEW YORK and VIENNA, Austria, Dec. 08, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (Nasdaq: HOOK), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform,
NEW YORK and VIENNA, Austria, Dec. 08, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (Nasdaq: HOOK), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform,
Gamida Cell (NASDAQ: GMDA) shares are trading higher on Monday following the company's Saturday GDA-201 presentation at the American Society of Hematology Annual Meeting. Gamida Cell is a biopharmace
NEW YORK and VIENNA, Austria, Dec. 07, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA'), a company developing a new class of immunotherapeutics based on its proprietary arenavi
NEW YORK and VIENNA, Austria, Nov. 30, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA'), a company developing a new class of immunotherapeutics based on its proprietary arenavi
NEW YORK and VIENNA, Austria, Nov. 03, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA'), a company developing a new class of immunotherapeutics based on its proprietary arenavi
Flamemaster (OTCMKTS:FAME) and HB Fuller (NYSE:FUL) are both construction companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitabilit
Nuveen Asset Management LLC boosted its holdings in shares of HB Fuller Co (NYSE:FUL) by 3.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (S
HB Fuller (NYSE:FUL) and Flamemaster (OTCMKTS:FAME) are both basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their dividends,
The Luxury Closet targets the resale of perfect condition items from high-end brands.
HOOKIPA Pharma Inc. (HOOK) delivered earnings and revenue surprises of 39.13% and 138.32%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Recap: HOOKIPA Pharma Q2 Earnings

11:20am, Thursday, 13'th Aug 2020
Shares of HOOKIPA Pharma (NASDAQ:HOOK) moved higher by 2.8% in pre-market trading after the company reported Q2 results.Quarterly Results Earnings per share increased 55.56% year over year to ($0.28),
NEW YORK and VIENNA, Austria, Aug. 13, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases
Lucara Diamond Corp. (OTCPK:LUCRF) Q2 2020 Earnings Conference Call August 11, 2020 10:00 ET Company Participants Eira Thomas - President and Chief Executive Officer Zara Boldt - Chief Financial Offic
The number of confirmed cases of the coronavirus that causes COVID-19 in the U.S. rose above 4.8 million on Thursday, a day after President Donald Trump...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE